These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23561318)

  • 1. Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace.
    Marinangeli CP; Jones PJ
    Nutr Res Rev; 2013 Jun; 26(1):12-21. PubMed ID: 23561318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceuticals and botanicals: overview and perspectives.
    Nicoletti M
    Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in discovering bioactives for the food industry.
    Schwager J; Mohajeri MH; Fowler A; Weber P
    Curr Opin Biotechnol; 2008 Apr; 19(2):66-72. PubMed ID: 18406130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keep taking the tomatoes--the exciting world of nutraceuticals.
    Jack DB
    Mol Med Today; 1995 Jun; 1(3):118-21. PubMed ID: 9415146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome.
    Marinangeli CP; Jones PJ
    Ann Med; 2010 Jul; 42(5):317-33. PubMed ID: 20486826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics--the friendly bacteria with market potential in global market.
    Khan SH; Ansari FA
    Pak J Pharm Sci; 2007 Jan; 20(1):76-82. PubMed ID: 17337434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Business considerations in the development of probiotics.
    Hoffman FA
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on "The challenge of translating nutrition research into public health nutrition". Session 4: Challenges facing the food industry in innovating for health. Regulatory challenges and opportunities for food innovation.
    Binns N
    Proc Nutr Soc; 2009 Feb; 68(1):1-10. PubMed ID: 19079824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.
    Gulati OP; Berry Ottaway P
    Toxicology; 2006 Apr; 221(1):75-87. PubMed ID: 16487647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the functional food market: from marketing issues and commercial players to future demand from life in space.
    Vergari F; Tibuzzi A; Basile G
    Adv Exp Med Biol; 2010; 698():308-21. PubMed ID: 21520721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current use and evolving landscape of nutraceuticals.
    Chopra AS; Lordan R; Horbańczuk OK; Atanasov AG; Chopra I; Horbańczuk JO; Jóźwik A; Huang L; Pirgozliev V; Banach M; Battino M; Arkells N
    Pharmacol Res; 2022 Jan; 175():106001. PubMed ID: 34826602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food for thought: IP protection for nutraceuticals and functional foods.
    Lapointe S
    Health Law Can; 2008 Jun; 28(3-4):101-11. PubMed ID: 19051970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutraceuticals tread business tightrope in Europe.
    Hodgson J
    Nat Biotechnol; 2002 Apr; 20(4):322-3. PubMed ID: 11923821
    [No Abstract]   [Full Text] [Related]  

  • 18. The regulation of foodstuffs with a specific health effect and health claims in Germany.
    Hermle S
    Food Drug Law J; 1998; 53(1):173-9. PubMed ID: 11795331
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and control of food safety risks: the role of governments, food producers, marketers, and academia.
    Lupien JR
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():74-9. PubMed ID: 17392080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agro-food industry growth and obesity in China: what role for regulating food advertising and promotion and nutrition labelling?
    Hawkes C
    Obes Rev; 2008 Mar; 9 Suppl 1():151-61. PubMed ID: 18307719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.